Ocular Therapeutix Reports Q3 2026 Quarterly Results — 8-K (Aug 3, 2026)

What Happened

• Ocular Therapeutix, Inc. (OCUL) announced its financial results for the quarter ended June 30, 2026 in a press release dated August 3, 2026. The company furnished the press release as Exhibit 99.1 to a Current Report on Form 8-K (filed Aug 3, 2026) under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: August 3, 2026; quarter covered: ended June 30, 2026.
• The earnings announcement was furnished (not filed) as Exhibit 99.1 to the Form 8-K.
• Exhibit list also includes the Inline XBRL cover page (Exhibit 104) per the filing.
• The Form 8-K entry is Item 2.02 (results of operations) with exhibits reported under Item 9.01.

Why It Matters

• This 8-K signals that Ocular Therapeutix has released its latest quarterly results; the press release (Exhibit 99.1) will contain the detailed numbers investors care about (revenue, net income or loss, and any commentary on operations or guidance). Because the release is furnished rather than filed, it is being provided for investor information pursuant to Item 2.02. Retail investors should review the attached press release and any related investor materials (earnings slides or webcast) to see the actual financial figures and management commentary.